Blue Square Asset Management, LLC Astrazeneca PLC Transaction History

Blue Square Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $809,509 - $885,710	-14,570 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$48.42 - $60.18 $59,411 - $73,840	-1,227 Reduced 7.77%	14,570 $873,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $38,010 - $43,878	806 Added 5.38%	15,797 $785,000
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $169,383 - $202,547	3,491 Added 30.36%	14,991 $749,000
Q3 2020 Nov 10, 2020	BUY	$53.07 - $61.1 $302,764 - $348,575	5,705 Added 98.45%	11,500 $630,000
Q2 2020 Aug 11, 2020	SELL	$43.1 - $55.31 $313,897 - $402,822	-7,283 Reduced 55.69%	5,795 $306,000
Q1 2020 Apr 28, 2020	SELL	$37.79 - $51.33 $134,267 - $182,375	-3,553 Reduced 21.36%	13,078 $584,000
Q4 2019 Feb 04, 2020	BUY	$42.46 - $50.46 $328,385 - $390,257	7,734 Added 86.93%	16,631 $829,000
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $356,947 - $404,546	8,897 New	8,897 $397,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Square Asset Management, LLC with notifications on news.